This is an independent comparison for prospective users; NoVo is not affiliated with the other tools named, and product features and pricing change — verify current specifics on each provider’s own site.
Both NoVo and SpotGamma surface dealer gamma levels, so they get compared — but they sit in different categories. SpotGamma is an analytics and research service; NoVo is a SPY, QQQ & IWM execution cockpit. Here’s the honest head-to-head (and a longer take on the alternative angle).
What SpotGamma does well
SpotGamma is a respected research product with broad coverage — gamma-exposure analysis, key levels, and commentary across many indices and names, aimed at helping traders and investors understand dealer positioning. If your goal is understanding the market broadly and you bring your own execution, it’s a strong, well-established choice with a research depth NoVo doesn’t try to match.
What NoVo does differently
NoVo is purpose-built for one job: SPY 0DTE scalping. It maps the dealer levels and — the part a research service doesn’t do — executes your trade in one click: strike selection, sizing to your risk, a protective stop, and a scaled exit ladder, in your own non-custodial broker. It’s narrower (three tickers, not dozens) and deeper (it acts, not just informs).
SpotGamma is where you go to understand the market. NoVo is where you understand and trade it, in one place, for SPY. Depth-of-research vs. depth-of-execution.
Which to pick
Pick SpotGamma for broad, multi-product gamma research when execution isn’t your bottleneck. Pick NoVo if you scalp SPY 0DTE and want the map plus disciplined one-click execution welded together — and want your money to stay in your own broker. Some traders even use both: research to understand the regime, NoVo to trade SPY. Neither claims a magic edge — both give you structure, not signals; the difference is whether the tool also puts the trade on for you — in one click, on your call.